Lars Erichsen Selected Research

Lars Erichsen Research Topics

4	Neoplasms (Cancer) 12/2022 - 09/2018
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019 - 01/2017
3	Carcinoma (Carcinomatosis) 09/2022 - 01/2018
3	Body Weight (Weight, Body) 12/2017 - 06/2003
2	Chronic Renal Insufficiency 05/2023 - 12/2022
2	Weight Loss (Weight Reduction) 01/2023 - 12/2021
2	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 09/2017
1	Hypertension (High Blood Pressure) 06/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2023
1	Melanoma (Melanoma, Malignant) 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Nijmegen Breakage Syndrome 01/2022
1	Obesity 12/2021
1	Nausea 12/2021
1	Overweight 12/2021
1	Malaria 05/2017
1	Hyponatremia 05/2011
1	Nocturia 05/2011
1	Insulin Resistance 10/2004

4	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 01/2018
4	Insulin Aspart (NovoLog)FDA Link 01/2019 - 06/2003
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 06/2003
2	cagrilintideIBA 01/2023 - 12/2021
2	CarbohydratesIBA 01/2018 - 12/2017
2	Insulin (Novolin)FDA Link 10/2004 - 06/2003
1	Angiotensin IIIBA 06/2023
1	CytokinesIBA 05/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2023
1	Islet Amyloid PolypeptideIBA 01/2023
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023
1	semaglutideIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	hydrogen sulfite (bisulfite)IBA 09/2022
1	CarbonIBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Liraglutide FDA Link 12/2021
1	AntibodiesIBA 01/2019
1	Retroelements (Retrotransposon)IBA 09/2018
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 09/2017
1	acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide FDA Link 09/2017
1	Hormones (Hormone)IBA 09/2017
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2017
1	VaccinesIBA 05/2017
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 05/2011
1	SodiumIBA 05/2011

1	Therapeutics 01/2022